145 related articles for article (PubMed ID: 35589642)
1. [Steroids-Resistant EGPA-Induced Neuropathy with Acute Disease Progression: How to Select Remission-Induction/Maintenance Therapy Based on The Characteristics].
Takeshita Y
Brain Nerve; 2022 May; 74(5):525-530. PubMed ID: 35589642
[TBL] [Abstract][Full Text] [Related]
2. [Steroids-Resistant EGPA-Induced Neuropathy with Acute Disease Progression: How to Use Mepolizumab as Novel Targeted Agent].
Hattori N
Brain Nerve; 2022 May; 74(5):531-536. PubMed ID: 35589643
[TBL] [Abstract][Full Text] [Related]
3. Anti-neutrophil Cytoplasmic Antibody-negative Eosinophilic Granulomatosis with Polyangiitis Complicated with Peripheral Neuropathy that Underwent Remission Induction with Mepolizumab Monotherapy.
Nishihara M; Suzuki M; Asatani S; Nagasawa Y; Tsukamoto M; Akiya K; Kobayashi H; Kitamura N; Nakamura H
Intern Med; 2023 Oct; 62(19):2895-2900. PubMed ID: 36725044
[TBL] [Abstract][Full Text] [Related]
4. Long-term Safety and Efficacy of Benralizumab for Eosinophilic Granulomatosis with Polyangiitis Complicated with Severe Neuropathy.
Koga Y; Yoshimi S; Harada T; Suzuki S; Ohtsuka T; Dobashi K; Hisada T
Intern Med; 2023 May; 62(10):1553-1556. PubMed ID: 36171130
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of high-dose intravenous immunoglobulin therapy for peripheral neuropathy in the remission stage of eosinophilic granulomatosis with polyangiitis (EGPA, Churg-Strauss syndrome).
Matsuda T; Arimura Y; Yoshihara K; Komagata Y; Kaname S; Yamada A
Nihon Rinsho Meneki Gakkai Kaishi; 2013; 36(4):217-25. PubMed ID: 23994800
[TBL] [Abstract][Full Text] [Related]
6. Mepolizumab administration for eosinophilic granulomatosis with polyangiitis in an elderly patient with an abrupt onset of limb ischaemia and peripheral neuropathy: A case-based literature review.
Terashima S; Yamaguchi M; Ishihara T; Hagita J; Katsuno T; Ito M; Sugiyama H; Iwagaitsu S; Nobata H; Kinashi H; Ishimoto T; Banno S; Ito Y
Mod Rheumatol Case Rep; 2023 Jan; 7(1):142-147. PubMed ID: 36107735
[TBL] [Abstract][Full Text] [Related]
7. Factors Affecting the Ability to Discontinue Oral Corticosteroid Use in Patients with EGPA Treated with Anti-Interleukin-5 Therapy.
Matsuno O
Int Arch Allergy Immunol; 2024; 185(2):116-123. PubMed ID: 37906985
[TBL] [Abstract][Full Text] [Related]
8. Early add-on administration of mepolizumab and intravenous immunoglobulin effective in treating eosinophilic granulomatosis with polyangiitis.
Ikeda T; Komatsu T; Yokoyama K; Takahashi K; Kawakami T
J Dermatol; 2021 Apr; 48(4):529-532. PubMed ID: 33305381
[TBL] [Abstract][Full Text] [Related]
9. Severe cardiomyopathy revealing antineutrophil cytoplasmic antibodies-negative eosinophilic granulomatosis with polyangiitis.
Bouiller K; Samson M; Eicher JC; Audia S; Berthier S; Leguy V; Humbert O; Martin L; Lorgis L; Cottin Y; Bonnotte B; Lorcerie B
Intern Med J; 2014 Sep; 44(9):928-31. PubMed ID: 25201426
[TBL] [Abstract][Full Text] [Related]
10. Rituximab as Induction Therapy in Eosinophilic Granulomatosis with Polyangiitis Refractory to Conventional Immunosuppressive Treatment: A 36-Month Follow-Up Analysis.
Thiel J; Troilo A; Salzer U; Schleyer T; Halmschlag K; Rizzi M; Frede N; Venhoff A; Voll RE; Venhoff N
J Allergy Clin Immunol Pract; 2017; 5(6):1556-1563. PubMed ID: 28916432
[TBL] [Abstract][Full Text] [Related]
11. Low-dose mepolizumab is effective as an add-on therapy for treating long-lasting peripheral neuropathy in patients with eosinophilic granulomatosis with polyangiitis.
Nakamura Y; Fukutomi Y; Sekiya K; Kajiwara K; Kawasaki Y; Fujita N; Nagayama K; Iwata M; Iwamoto K; Yano K; Hamada Y; Watai K; Ryu K; Hayashi H; Kamide Y; Taniguchi M
Mod Rheumatol; 2022 Feb; 32(2):387-395. PubMed ID: 34910206
[TBL] [Abstract][Full Text] [Related]
12. A rare case report of polyangiitis overlap syndrome: granulomatosis with polyangiitis and eosinophilic granulomatosis with polyangiitis.
Quan MV; Frankel SK; Maleki-Fischbach M; Tan LD
BMC Pulm Med; 2018 Nov; 18(1):181. PubMed ID: 30497438
[TBL] [Abstract][Full Text] [Related]
13. Successful early introduction of mepolizumab for peripheral neuropathy with a peripheral circulatory disorder in a patient with myeloperoxidase anti-neutrophil cytoplasmic antibody-negative eosinophilic granulomatosis with polyangiitis.
Nishihara M; Hamaguchi M; Ikumi N; Nishiwaki A; Sugiyama K; Nagasawa Y; Tsuzuki H; Yoshizawa S; Tanikawa Y; Asatani S; Kobayashi H; Takei M; Kitamura N
Mod Rheumatol Case Rep; 2021 Jul; 5(2):354-359. PubMed ID: 33970058
[TBL] [Abstract][Full Text] [Related]
14. [Neurological disorders in eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome)].
Gilyarov MY; Belikova LP; Shchukin IA; Fidler MS; Avakyan GG; Shustrova GE; Martynov MY; Svet AV
Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(10):93-102. PubMed ID: 28635862
[TBL] [Abstract][Full Text] [Related]
15. Polyangiitis overlap syndrome of granulomatosis with polyangiitis (Wegener's granulomatosis) and eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome).
Uematsu H; Takata S; Sueishi K; Inoue H
BMJ Case Rep; 2014 Feb; 2014():. PubMed ID: 24577169
[TBL] [Abstract][Full Text] [Related]
16. [Current treatment of eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome)].
Moosig F; Holle J
Z Rheumatol; 2019 May; 78(4):333-338. PubMed ID: 30627842
[TBL] [Abstract][Full Text] [Related]
17. Adding Azathioprine to Remission-Induction Glucocorticoids for Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss), Microscopic Polyangiitis, or Polyarteritis Nodosa Without Poor Prognosis Factors: A Randomized, Controlled Trial.
Puéchal X; Pagnoux C; Baron G; Quémeneur T; Néel A; Agard C; Lifermann F; Liozon E; Ruivard M; Godmer P; Limal N; Mékinian A; Papo T; Ruppert AM; Bourgarit A; Bienvenu B; Geffray L; Saraux JL; Diot E; Crestani B; Delbrel X; Sailler L; Cohen P; Le Guern V; Terrier B; Groh M; Le Jeunne C; Mouthon L; Ravaud P; Guillevin L;
Arthritis Rheumatol; 2017 Nov; 69(11):2175-2186. PubMed ID: 28678392
[TBL] [Abstract][Full Text] [Related]
18. Methotrexate versus cyclophosphamide for remission maintenance in ANCA-associated vasculitis: A randomised trial.
Maritati F; Alberici F; Oliva E; Urban ML; Palmisano A; Santarsia F; Andrulli S; Pavone L; Pesci A; Grasselli C; Santi R; Tumiati B; Manenti L; Buzio C; Vaglio A
PLoS One; 2017; 12(10):e0185880. PubMed ID: 29016646
[TBL] [Abstract][Full Text] [Related]
19. Eosinophilic granulomatosis with polyangitis: A new target for biologicals.
Bayrak Durmaz MS; Çelebi Sözener Z; Bavbek S
Tuberk Toraks; 2022 Mar; 70(1):93-101. PubMed ID: 35362309
[TBL] [Abstract][Full Text] [Related]
20. Two cases of refractory eosinophilic granulomatosis with polyangiitis wherein mepolizumab was effective against pulmonary and ear lesions.
Ushio Y; Wakiya R; Kato M; Kameda T; Nakashima S; Shimada H; Mansour MMF; Sugihara K; Miyashita T; Kadowaki N; Dobashi H
Mod Rheumatol Case Rep; 2021 Jul; 5(2):327-332. PubMed ID: 33533698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
